Race, ethnicity and ancestry in global diabetes research: grappling with complexity to advance equity and scientific integrity - a narrative review and viewpoint
- PMID: 40770495
- DOI: 10.1007/s00125-025-06516-1
Race, ethnicity and ancestry in global diabetes research: grappling with complexity to advance equity and scientific integrity - a narrative review and viewpoint
Abstract
The global burden of diabetes-across major forms such as type 2 diabetes, type 1 diabetes and gestational diabetes mellitus-disproportionately affects people of non-European ancestry, the majority of whom live in low- and middle-income countries. The heterogeneity of diabetes risks and phenotypes indicates that knowledge derived principally from European-origin populations may not be readily transferable to other groups. In this review our aim is to enhance the quality of diabetes research by championing the inclusion of diverse populations, ensuring clarity of population definition and encouraging exploration of population differences. We review the terminology used to define populations and make recommendations on the use of these terms. We argue that population membership by itself does not determine risks or response to intervention; rather, it is the confluence of genetic, environmental, sociocultural and policy factors that are causal and should be identified. We note that, while common diabetes forms are polygenic and populations are unlikely to harbour single genes that account for significant risk, environmental change that impacts lifestyle and biology demonstrably alters diabetes risk and provides opportunities for effective intervention. Similarly, while genetic variants are associated with adverse events, population group membership may sometimes not be a valid proxy for such variants, which has implications for healthcare equity. For most drugs used in diabetes there is little evidence that drug responsiveness materially differs by population grouping, although it is only recently that well-designed studies have been performed. In contrast, other population characteristics, such as sex, age and obesity, appear to alter glucose-lowering drug effectiveness and should be considered when prescribing. Inclusion of diverse populations in diabetes research, combined with a multidisciplinary approach, is essential if we are to combat the global burden of diabetes.
Keywords: Equity, diversity and inclusion; Genetics; Intergenerational diabetes risks; Population groups; Population stratification; Review; Structural and environmental determinants of health.
© 2025. The Author(s).
Conflict of interest statement
Funding: This work received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. Authors’ relationships and activities: NC reports receiving funds from AstraZeneca for serving on data safety and management committees of clinical trials sponsored by the company. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work. Contribution statement: All authors were responsible for drafting the article and reviewing it critically for important intellectual content. All authors approved the version to be published.
Similar articles
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646068
-
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948. Health Technol Assess. 2024. PMID: 39367772 Free PMC article.
-
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601. Zhonghua Jie He He Hu Xi Za Zhi. 2025. PMID: 40050074 Chinese.
-
Short-Term Memory Impairment.2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
References
-
- GBD 2021 Diabetes Collaborators (2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 402(10397):203–234. https://doi.org/10.1016/S0140-6736(23)01301-6 - DOI
-
- Wang H, Li N, Chivese T et al (2022) IDF Diabetes Atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s criteria. Diabetes Res Clin Pract 183:109050. https://doi.org/10.1016/j.diabres.2021.109050 - DOI - PubMed
-
- Green A, Hede SM, Patterson CC et al (2021) Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia 64(12):2741–2750. https://doi.org/10.1007/s00125-021-05571-8 - DOI - PubMed - PMC
-
- World Population Review (2025) Population by Continent 2025. Available from https://worldpopulationreview.com/continents . Accessed 27 Jun 2025
-
- Kehlenbrink S, Ansbro E, Besancon S, Hassan S, Roberts B, Jobanputra K (2022) Strengthening diabetes care in humanitarian crises in low- and middle-income settings. J Clin Endocrinol Metab 107(9):e3553–e3561. https://doi.org/10.1210/clinem/dgac331 - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources